Quinidine Polygalacturonate

CHEMBL1201486 Phase 4 Approuvé Small molecule

Half-Life

—

Bioavailability

—

Protein Binding

—

Molecular Weight

— g/mol

LogP

—

Phase

4

A polygalacturonate form of quinidine with the same therapeutic properties. An antiarrhythmic medication derived from cinchona bark, used to restore and maintain normal heart rhythm in conditions like atrial fibrillation.

Aires thérapeutiques

Cardiovascular Disease Pain Management Alzheimer's Disease Parkinson's Disease Migraine Schizophrenia Multiple Sclerosis Non-Alcoholic Fatty Liver Disease Stroke Major Depressive Disorder Chronic Pain Malaria Heart Failure Atrial Fibrillation

Pharmacokinetics (PK)

Pharmacodynamics (PD)

HBD / HBA

- / -

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Foire aux questions

A polygalacturonate form of quinidine with the same therapeutic properties. An antiarrhythmic medication derived from cinchona bark, used to restore and maintain normal heart rhythm in conditions like atrial fibrillation.

Yes, Quinidine Polygalacturonate is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1201486. Open-access bioactivity database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-02-27.

PillFYI

Vous cherchez des informations accessibles aux patients ?

Quinidine Polygalacturonate sur PillFYI

Données Clés

Liens externes

ChEMBL CHEMBL1201486

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

Avertissement médical

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.